A Prospective, Multicenter Study on Best Clinical Use of Imatinib in the Advanced Gastrointestinal Stromal Tumors
Clinical trial NCT00940563 · COMPLETED
Trial details
- NCT number
- NCT00940563
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-03-01
- Primary completion
- 2004-08-01
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.